title: The future of clinical trials in secondary prevention after acute coronary syndromes.
authors.affiliation: Department of Cardiology, Hospital General Universitario Gregorio Marañón, Dr. Esquerdo 46, Madrid, Spain. hecbueno@jet.es
authors.forename: Héctor
authors.initials: H
authors.lastname: Bueno
authors.forename: Paul W
authors.initials: PW
authors.lastname: Armstrong
authors.forename: Martin J
authors.initials: MJ
authors.lastname: Buxton
authors.forename: Nicolas
authors.initials: N
authors.lastname: Danchin
authors.forename: Jacobus
authors.initials: J
authors.lastname: Lubsen
authors.forename: Edmond
authors.initials: E
authors.lastname: Roland
authors.forename: Freek W
authors.initials: FW
authors.lastname: Verheugt
authors.forename: Andrew
authors.initials: A
authors.lastname: Zalewski
authors.forename: Neville
authors.initials: N
authors.lastname: Jackson
authors.forename: Michel
authors.initials: M
authors.lastname: Komajda
authors.forename: Ph Gabriel
authors.initials: PG
authors.lastname: Steg
mesh_terms: D054058:Acute Coronary Syndrome / Q000517:prevention & control*; D003365:Costs and Cost Analysis; D006801:Humans; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic / Q000331:legislation & jurisprudence / Q000379:methods / Q000639:trends*; D012042:Registries; D012107:Research Design / Q000592:standards; D018570:Risk Assessment; D018401:Sample Size; D055502:Secondary Prevention; D013223:Statistics as Topic; D016896:Treatment Outcome